[1]
Sehgal, V.K., Vashisht, T., Singh, G. and Sharma, N. 2019. A Pharmacoeconomic Analysis to Determine the Relative Cost-effectiveness of Timolol 0.5%, Brinzolamide 1% and Brimonidine 0.2% Eye Drops in Treatment of Primary Open Angle Glaucoma/Ocular Hypertension. International Journal of Medical and Dental Sciences. (Jul. 2019), 1766–1774. DOI:https://doi.org/10.18311/ijmds/2019/23420.